ImmunityBio begins first European treatments for bladder cancer
The milestone extends the company's commercial footprint for its bladder cancer therapy into Europe.
Read at Simply Wall St โThe milestone extends the company's commercial footprint for its bladder cancer therapy into Europe.
Read at Simply Wall St โ